Kazia Therapeutics (Germany) Today

Equity ratings for Kazia Therapeutics Ltd are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of March 2021 and ending today, the 3rd of August 2021. Click here to learn more.
Kazia Therapeutics Ltd cannot be verified against its exchange. Apparently, Kazia Therapeutics is not available for investing at the moment. Please verify the symbol is currently traded on Stuttgart Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Kazia Therapeutics Stock Profile

Novogen Limited is engaged in the pharmaceutical research and development business in Australia.. The public information regarding Kazia Therapeutics Ltd's current market price is not available at this time.
Kazia Therapeutics is not yet fully synchronised with the market data
Kazia Therapeutics has some characteristics of a very speculative penny stock
Kazia Therapeutics is unlikely to experience financial distress in the next 2 years
The company reported the revenue of 1.58 M. Net Loss for the year was (5.28 M).
Kazia Therapeutics Ltd has accumulated about 6.36 M in cash with (4.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Legal NameKazia Therapeutics Ltd
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Kazia Therapeutics' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
Kazia Therapeutics Ltd (NV9) is traded on Stuttgart Stock Exchange in Germany and employs 5 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 46.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kazia Therapeutics's market, we take the total number of its shares issued and multiply it by Kazia Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Kazia Therapeutics has 250 M outstanding shares. Kazia Therapeutics Ltd has accumulated about 6.36 M in cash with (4.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check Kazia Therapeutics Probability Of Bankruptcy

Kazia Stock Against Markets

Picking the right benchmark for Kazia Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Kazia Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Kazia Therapeutics is critical whether you are bullish or bearish towards Kazia Therapeutics Ltd at a given time.
Kazia Therapeutics Ltd cannot be verified against its exchange. Apparently, Kazia Therapeutics is not available for investing at the moment. Please verify the symbol is currently traded on Stuttgart Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kazia Therapeutics stock to make a market-neutral strategy. Peer analysis of Kazia Therapeutics could also be used in its relative valuation, which is a method of valuing Kazia Therapeutics by comparing valuation metrics with similar companies.
Check out Stocks Correlation. Note that the Kazia Therapeutics information on this page should be used as a complementary analysis to other Kazia Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Tools for Kazia Stock

When running Kazia Therapeutics price analysis, check to measure Kazia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kazia Therapeutics is operating at the current time. Most of Kazia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kazia Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kazia Therapeutics' price. Additionally, you may evaluate how the addition of Kazia Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go